📰 Practice Guidelines News
Page 19 - Practice Guidelines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.
July 20, 2023
Ahmed Elkhanany, MD discusses unmet needs in patients with estrogen receptor–positive breast cancer who progress on frontline therapy, treatment considerations for these patients, and how FES PET imaging may benefit this population.
July 19, 2023
Highlights: Total Val-d’Or properties gold mineral resources currently stand at 3,793,900 ounces Measured and Indicated (“M&I”) and 1,418,700 ounces...
July 19, 2023
Highlights: Total Val-d'Or properties gold mineral resources currently stand at 3,793,900 ounces Measured and Indicated and 1,418,700 ounces Inferred along all trends and deposits, representing a 28% increase from the 2021 Mineral Resource Estimate.... - Veroeffentlicht am 19.07.2023
July 11, 2023
Leading investigators in the multiple myeloma field discuss the latest clinical trial findings, many of which were presented during the 2023 ASCO Annual Meeting.
July 10, 2023
The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.
June 27, 2023
Barcelona, Spain - Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global leader in plasma medicines, has started marketing XEMBIFY®, its 20% subcutaneous immunoglobulin, in Spain. This plasma medicine is indicated for treating primary immunodeficiencie...
June 26, 2023
June 26, 2023 Grifols begins European launch of XEMBIFY® in Spain to treat immunodeficiencies Print this news Download the press release Primary immunodeficiencies (PID) affect...
June 26, 2023
LITHIUM RESOURCES UPDATE PASTOS GRANDES PROJECT SALTA PROVICE, ARGENTINA PREPARED FOR PREPARED BY Frederik Reidel, CPG Effective Date...
June 23, 2023
23.06.2023 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Trodelvy (sacituzumab govitecan) as monotherapy for the ...